ALAMEDA, Calif., Sept. 18, 2007 (PRIME NEWSWIRE) -- Avigen, Inc. (Nasdaq:AVGN) a biopharmaceutical company innovating therapeutics for chronic neurological care, announced today that President and CEO Kenneth Chahine will present information on Avigen's development programs and product pipeline at the UBS 2007 Global Life Sciences Conference. Dr. Chahine will present on Tuesday, September 25, 2007, from 10:00 to 10:25 a.m. EDT at the Grand Hyatt Hotel in New York City.
